Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046427 | PMC |
| http://dx.doi.org/10.1136/bcr-2020-234475 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The presence of cell surface protein CD47 allows cancer cells to evade innate and adaptive immune surveillance resulting in metastatic spread. CD47 binds to and activates SIRPα on the surface of myeloid cells, inhibiting their phagocytic activity. On the other hand, CD47 binds the matricellular protein Thrombospondin-1, limiting T-cell activation.
View Article and Find Full Text PDFThe CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo.
Cancers (Basel)
April 2023
Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, University of Sheffield, Sheffield S10 2RX, UK.
CDK 4/6 inhibitors have demonstrated significant improved survival for patients with estrogen receptor (ER) positive breast cancer (BC). However, the ability of these promising agents to inhibit bone metastasis from either ER+ve or triple negative BC (TNBC) remains to be established. We therefore investigated the effects of the CDK 4/6 inhibitor, palbociclib, using in vivo models of breast cancer bone metastasis.
View Article and Find Full Text PDFGenomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models.
PNAS Nexus
November 2022
Department of Oral and Craniofacial Molecular Biology, Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
Article Synopsis
- Triple negative breast cancer (TNBC) is responsible for over 30% of breast cancer deaths, yet it represents only 10-15% of all cases, highlighting a significant challenge in treatment.
- Research using CRISPR/Cas9 screening identified that TNBC cells are particularly sensitive to the depletion of UBA1, a ubiquitin-like modifier activating enzyme.
- The UBA1 inhibitor TAK-243 induces severe ER stress and cell death in TNBC cells, particularly those with high c-MYC levels, showing promise for shrinking tumors and reducing metastasis in both lab models and patient-derived xenografts.
A rare complication of Behçet's disease in a 12-year-old girl: a large intracardiac thrombosis.
Cardiol Young
June 2023
Pediatric Rheumatology, Akdeniz University Medical School, Antalya, Turkey.
Behcet's disease is a multi-systemic inflammatory disease with a clinical spectrum as a triple complex of recurrent oral, genital ulcers, and uveitis. Cardiac involvement in patients with Behcet's disease is extremely rare and often associated with poor prognosis. Behcet's disease should be considered in the differential diagnosis of right ventricular mass especially in young adults, even there is no typical clinical features of Behcet's disease.
View Article and Find Full Text PDFFunctional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers.
Mol Cancer Res
November 2022
Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Unlabelled: Long noncoding RNAs have been implicated in many of the hallmarks of cancer. Herein, we found that the expression of lncRNA152 (lnc152; a.k.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!